[1] |
Herrero JI. De novo malignancies following liver transplantation:impact and recommendations[J]. Liver Transpl, 2009, 5(Suppl 2):S90-S94. https://www.researchgate.net/publication/51439218_De_Novo_Malignancies_Following_Liver_Transplantation_Impact_and_Recommendations
|
[2] |
Feng S, Ekong UD, Lobritto SJ, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants[J]. JAMA, 2012, 307(3):283-293. http://jamanetwork.com/journals/jama/fullarticle/1104871
|
[3] |
Pons JA, Ramírez P, Revilla-Nuin B, et al. Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients[J]. Clin Transplant, 2009, 23(3):329-336. doi: 10.1111/ctr.2009.23.issue-3
|
[4] |
唐韵成, 曾强, 窦剑.调节性T细胞在器官移植免疫耐受中的研究进展[J].器官移植, 2014, 5(1):54-56. http://www.organtranspl.com/browse/detail/qkid/84/id/242.htmlTang YC, Zeng Q, Dou J. Advances on regulatory T cells in immune tolerance of organ transplantation[J]. Organ Transplant, 2014, 5(1):54-56. http://www.organtranspl.com/browse/detail/qkid/84/id/242.html
|
[5] |
Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts[J]. Nature, 1969, 223(5205):472-476. doi: 10.1038/223472a0
|
[6] |
Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers[J]. Lancet, 1990, 336(8714):519-523. doi: 10.1016/0140-6736(90)92082-S
|
[7] |
Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation:the basis of graft acceptance[J]. Hepatology, 1993, 17(6):1127-1152. doi: 10.1002/(ISSN)1527-3350
|
[8] |
Ponton C, Vizcaíno L, Tomé S, et al. Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction[J]. Transplant Proc, 2010, 42(2):656-659. doi: 10.1016/j.transproceed.2010.02.006
|
[9] |
Tryphonopoulos P, Ruiz P, Weppler D, et al. Long-term follow-up of 23 operational tolerant liver transplant recipients[J]. Transplantation, 2010, 90(12):1556-1561. doi: 10.1097/TP.0b013e3182003db7
|
[10] |
Benítez C, Londoño MC, Miquel R, et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients[J]. Hepatology, 2013, 58(5):1824-1835. doi: 10.1002/hep.26426
|
[11] |
Ohe H, Waki K, Yoshitomi M, et al. Factors affecting operational tolerance after pediatric living-donor liver transplantation:impact of early post-transplant events and HLA match[J]. Transpl Int, 2012, 25(1):97-106. doi: 10.1111/tri.2011.25.issue-1
|
[12] |
de la Garza RG, Sarobe P, Merino J, et al. Trial of complete weaning from immunosuppression for liver transplant recipients:factors predictive of tolerance[J]. Liver Transpl, 2013, 19(9):937-944. doi: 10.1002/lt.v19.9
|
[13] |
Martínez-Llordella M, Puig-Pey I, Orlando G, et al. Multiparameter immune profiling of operational tolerance in liver transplantation[J]. Am J Transplant, 2007, 7(2):309-319. doi: 10.1111/ajt.2007.7.issue-2
|
[14] |
Pons JA, Revilla-Nuin B, Baroja-Mazo A, et al. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal[J]. Transplantation, 2008, 86(10):1370-1378. doi: 10.1097/TP.0b013e318188d3e6
|
[15] |
Shalev I, Selzner N, Shyu W, et al. Role of regulatory T cells in the promotion of transplant tolerance[J]. Liver Transpl, 2012, 18(7):761-770. doi: 10.1002/lt.v18.7
|
[16] |
Zhao X, Li Y, Ohe H, et al. Intragraft Vδ1γδ T cells with a unique T-cell receptor are closely associated with pediatric semiallogeneic liver transplant tolerance[J]. Transplantation, 2013, 95(1):192-202. doi: 10.1097/TP.0b013e3182782f9f
|
[17] |
Schulz-Juergensen S, Marischen L, Wesch D, et al. Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression[J]. Pediatr Transplant, 2013, 17(4):348-354. doi: 10.1111/petr.2013.17.issue-4
|
[18] |
Li L, Wozniak LJ, Rodder S, et al. A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation[J]. Am J Transplant, 2012, 12(5):1218-1228. doi: 10.1111/j.1600-6143.2011.03928.x
|
[19] |
Martínez-Llordella M, Lozano JJ, Puig-Pey I, et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients[J]. J Clin Invest, 2008, 118(8):2845-2857. http://www.oalib.com/references/13676475
|
[20] |
Natarajan S, Thomson AW. Tolerogenic dendritic cells and myeloid-derived suppressor cells:potential for regulation and therapy of liver auto-and alloimmunity[J]. Immunobiology, 2010, 215(9/10):698-703.
|
[21] |
Luan Y, Mosheir E, Menon MC, et al. Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion[J]. Am J Transplant, 2013, 13(12):3123-3131. doi: 10.1111/ajt.12461
|